SPONSOR
CHU de Quebec-Universite Laval
Total Trials
4
Recruiting
4
Phases
Phase 2
Conditions studied: Non-Muscle Invasive Bladder CancerIntraocular PressureRetinal DetachmentHypoparathyroidism PostproceduralQuality of Life
CHU de Quebec-Universite Laval is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Non-Muscle Invasive Bladder Cancer, Intraocular Pressure, Retinal Detachment, Hypoparathyroidism Postprocedural.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — CHU de Quebec-Universite Laval
How many clinical trials has CHU de Quebec-Universite Laval sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by CHU de Quebec-Universite Laval, of which 4 are actively recruiting participants. These trials cover conditions including Non-Muscle Invasive Bladder Cancer, Intraocular Pressure, Retinal Detachment. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does CHU de Quebec-Universite Laval research focus on?
CHU de Quebec-Universite Laval clinical trials span Non-Muscle Invasive Bladder Cancer, Intraocular Pressure, Retinal Detachment, Hypoparathyroidism Postprocedural, Quality of Life. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a CHU de Quebec-Universite Laval clinical trial?
To participate in a CHU de Quebec-Universite Laval trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all CHU de Quebec-Universite Laval trials with current recruitment status updated daily.
Clinical Trials by CHU de Quebec-Universite Laval
NCT05327647 Phase 2
Recruiting
A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer
Non-Muscle Invasive Bladder Cancer
NCT06522867
Recruiting
Evaluation of Intraocular Pressure Following a Vitreoretinal Surgery Using Goldmann Applanation Tonometry, Icare and Accupen
Intraocular Pressure
NCT05863312
Recruiting
REtinal Detachment Outcomes Study
Retinal Detachment
NCT03249012
Recruiting
Quality of Life Related to Different Treatment Protocols for Post-thyroidectomy Hypoparathyroidism
Hypoparathyroidism Postprocedural
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology